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Summary
Background:  Preoperative  embolization  decreases  the  intraoperative  risk  of  hemorrhage  in
spinal decompression  surgery  of  hypervascular  metastases  such  as  renal  cell  carcinoma.  There
is no  consensus  concerning  embolization  in  other  metastases.  The  purpose  of  this  study  was  to
compare the  intraoperative  amount  of  blood  loss  in  embolized  versus  non-embolized  patients,
seeking for  differences  depending  on  the  primary  tumor  and  the  extent  of  surgery.
Patients and  methods:  Ninety-three  patients,  average  age  60.5  years,  were  operated.  The
origins of  metastases  were:  28  breast  cancer  (30.1%),  19  pulmonary  carcinoma  (20.4%),  16  renal
cell carcinoma  (17.2%),  30  other  cancers  (32.3%).  Surgical  procedures  were:  52  thoracolumbar
laminectomies  with  instrumentation,  29  thoracolumbar  corpectomies  or  vertebrectomies,  12
cervical corpectomies.  A  preoperative  microsphere  embolization  was  performed  in  35  patients.
Blood loss  was  evaluated  by:  blood  volume  in  surgical  aspiration  devices,  number  of  transfused
packed red  blood  cells  units  and  hemoglobin  variation  during  surgery.
Results:  Renal  metastases  were  systematically  embolized.  In  the  breast  group,  there  was  no
signiﬁcant  difference  (P  >  0.05)  in  blood  loss  between  embolization  versus  non-embolization.
In the  pulmonary  group  and  in  other  metastases,  no  difference  was  found  either.  The  extent
of surgery  (corpectomy/vertebrectomy  versus  thoracolumbar  instrumentation  and  cervical  cor-
pectomy)  increased  bleeding:  breast  1775  ml  versus  778  ml  and  600  ml  respectively  (P  =  0.048),
pulmonary 2500  ml  versus  430  ml  and  180  ml  (P  =  0.020),  renal  3346  ml  versus  1175  ml  and  780  ml
(P =  0.036)  and  others  1550  ml  versus  474  ml  and  400  ml  (P  =  0.020).
decreases  the  risk  of  hemorrhage  in  highly  vascularized  metastasesConclusions:  Embolization  
such as  renal  cell  carcinoma.  A  beneﬁt  of  embolization  was  not  found  for  metastases  of  breast
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or  pulmonary  tumors.  As  far  as  other  metastases,  thyroid  carcinoma  should  be  analyzed  on
a greater  cohort.  The  extent  of  surgery  remains  an  important  risk  factor  for  intraoperative
bleeding.  A  preoperative  angiogram  should  be  carried  out  in  all  types  of  metastases  prior  to
a thoracolumbar  corpectomy  or  vertebrectomy  to  perform  an  embolization  if  the  tumor  is
hypervascular.
Level of  evidence:  Level  IV,  retrospective  study.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Metastatic  vertebral  lesions  can  severely  reduce  the  quality
of  life  in  terms  of  tumor-associated  pain,  pathologic
fractures  and  the  risk  of  paraplegia.  Surgical  stabilization
and  neural  decompression  belong  to  the  standards  of  onco-
logic  management  of  spinal  metastases.  However,  certain
metastatic  lesions  present  an  elevated  risk  of  hemorrhage
and  transarterial  embolization  was  found  to  be  a  valuable
method  of  decreasing  intraoperative  bleeding  [1—3].
Metastases  of  well-vascularized  primary  tumors,  such  as
renal  cell  carcinoma,  are  frequently  found  in  the  spine.
About  65  to  75%  of  these  metastases  are  themselves  hyper-
vascularized  [2,4]. Therefore,  there  is  a  risk  of  massive
blood  loss  in  renal  cell  carcinoma.  When  embolization  is  not
performed,  bleeding  and  technical  difﬁculty  may  increase,
which  inhibits  sufﬁcient  removal  of  metastatic  tissue  and
augments  the  patient’s  morbidity  [5].
However,  it  remains  unclear  if  it  is  useful  to  embolize
metastases  of  other  primary  tumors  such  as  hepatocellular
carcinoma,  germ  cell  tumors,  and  neuroendocrine  tumors.
Other  hypervascular  tumors  such  as  thyroid  carcinoma
is  still  controversial  [6,7]  and  melanoma  do  not  seem  to
be  amenable  to  embolization  [8].  The  possible  effect  of
preoperative  embolization  in  frequent  metastases  such
as  breast  cancer  or  pulmonary  carcinoma  has  not  been
published  to  our  knowledge.
This  retrospective  study  was  conducted  to  compare  the
intraoperative  amount  of  blood  loss  in  embolized  versus  non-
embolized  patients  who  underwent  surgical  treatment  of
spinal  metastases,  seeking  for  differences  depending  on  the
primary  tumor  as  well  as  the  extent  of  the  surgical  proce-
dure.
Patients and methods
Patients
Institutional  review  board  approval  was  obtained  for  this
retrospective  study.  A  total  of  93  consecutive  patients  with
spinal  metastasis  were  operated  by  three  senior  surgeons  in
our  department  between  March  2000  and  December  2009.
The  average  age  at  operation  was  60.5  (range  34—81)  years.
There  were  51  male  (54.8%)  and  42  female  (45.2%)  patients.
Patients  were  regularly  followed  up  clinically  and  radio-
graphically  by  their  operating  surgeon.  Thirty  out  of  93
patients  (32.3%)  presented  more  than  one  metastatic  verte-
bral  level.  A  total  of  132  levels  were  operated:  27  cervical,
76  thoracic  and  29  lumbar.  Forty-eight  out  of  93  patients
s
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i51.6%)  had  associated  visceral  metastases.  Surgical  indica-
ions  were  either  curative  in  cases  of  single  metastasis,  or
alliative  if  the  metastasis  inﬁltrated  surrounding  tissues,  if
everal  metastases  or  a  pathologic  fracture  were  present.
ypes  of  primary  tumors
our  main  groups  of  different  metastases  origins  were  lined
ut  in  93  patients:  28  breast  (30.1%),  19  pulmonary  (20.4%),
6  renal  (17.2%)  and  30  other  tumors  (32.3%).
The  origins  of  other  tumors  was  composed  of:  ﬁve  col-
rectal,  four  prostate,  three  esophagus,  three  melanoma,
hree  urothelial  carinoma,  two  thyroid,  two  pharynx,  two
terus,  one  corticosurelanoma,  one  hepatocarcinoma,  one
hondrosarcoma,  one  Ewing  sarcoma,  one  non-Hodgkin  lym-
homa  and  one  neuroendocrine  tumor.
urgical  procedures
hree  different  categories  of  surgical  intervention  were
eﬁned:
 posterior  instrumentation  of  the  thoracolumbar  spine
associated  with  a  laminectomy  and  a  partial  tumorectomy
if  necessary;
 thoracolumbar  corpectomy  or  vertebrectomy  with  an
anterior  cage  implantation  and  a  posterior  instrumenta-
tion;
 cervical  corpectomy  using  an  anterior  plate  with  either  a
cage  or  the  iliac  crest  for  the  replacement  of  the  vertebral
body.
The  respective  numbers  of  patients  in  each  of  these
ategories  were:  52  in  group  (1),  29  in  group  (2)  and  12  in
roup  (3).
reoperative  embolization
 preoperative  embolization  was  performed  in  35  out  of
3  patients.  In  this  retrospective  cohort,  except  for  one
ase,  renal  cell  carcinoma  was  systematically  embolized.
he  choice  of  embolization  for  other  metastases  types
as  based  on  two  main  criteria:  preoperative  magnetic
esonance  characteristics  indicating  hypervascularity  by
ontrast  media  enhancement  or  in  patients  for  whom  radical
urgery  was  planned.  A  superselective  catheter  technique
as  used  to  perform  an  angiography  through  a  femoral
pproach  ﬁrst.  Once  the  vascular  bed  of  the  tumor  was
dentiﬁed,  the  embolization  was  realized  using  microspheres
5 N.  Robial  et  al.
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ith  a  diameter  ranging  from  500  to  700  m  (Embosphere®,
ioSphere  Medical,  Rockland,  MA).  The  embolization  was
erformed  within  48  h  prior  to  surgery  to  avoid  the  revas-
ularization  of  the  tumor.  Selective  catheterization  of
ntercostal  or  lumbar  segmental  arteries  was  also  used  to
heck  if  there  was  a  direct  link  between  the  Adamkiewicz
rtery  and  the  tumor  vascularization.  This  was  the  case  in
wo  patients,  where  the  embolization  was  performed  par-
ially  in  order  to  preserve  the  blood  supply  to  the  anterior
pinal  artery.
arameters  describing  blood  loss
hree  parameters  were  used  to  quantify  the  amount  of  blood
oss  during  surgery  and  the  immediate  postoperative  period:
 the  intraoperative  blood  volume  in  the  suction  was  mea-
sured  in  milliliters;
 the  number  of  transfused  packed  red  blood  cell  units  until
the  ﬁfth  day  after  surgery;
 the  hemoglobin  variation  from  the  beginning  to  the
end  of  surgery  was  calculated  in  gram  per  deciliter,
adjusted  to  the  number  of  transfused  packed  red  blood,
using  the  formula:  hemoglobin  variation  =  (hemoglobin
initial  —  hemoglobin  ﬁnal)  +  number  of  transfused  packed
red  blood  cell  during  surgery.  One  packed  red  blood  cell
unit  was  considered  to  increase  the  hemoglobin  rate  by
1  g/dl.
tatistics
tatistical  evaluation  was  performed  with  R  statistical
oftware  version  2.10.1  (http://www.R-project.org). A
uantitative  evaluation  has  been  performed  for  each  type
f  metastasis  prior  to  further  statistical  evaluation  in  dif-
erent  primary  tumor  subgroups.  The  effect  of  embolization
n  the  amount  of  blood  loss  and  the  hemoglobin  variation
as  evaluated  for  each  type  of  primary  tumor  using  a  linear
egression  model  adjusted  on  the  type  of  surgery.  A  Poisson
odel  was  used  to  investigate  the  inﬂuence  of  embolization
n  the  number  of  transfused  packed  red  blood  cells.  The
igniﬁcance  level  was  set  at  P  <  0.05.
esults
lood  volume  in  suction  during  surgery
he  analysis  of  intraoperative  blood  loss  by  quantifying  the
olume  in  the  suction  did  not  show  signiﬁcant  differences
etween  the  tumor  subgroups.  However,  the  type  of  sur-
ical  procedure  did  signiﬁcantly  inﬂuence  the  amount  of
lood  loss.  Corpectomies  and  vertebrectomies  increased  the
verage  volume  of  blood  loss  compared  to  thoracolumbar
ecompressions  with  instrumentation  and  cervical  corpec-
omies  (Table  1).umber  transfused  packed  red  blood  cell  units
he  same  observation  was  made  when  considering  the
verage  number  of  transfused  red  blood  cell  units  in  the
T
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tigure  1  Magnetic  resonance  imaging  of  a  single  breast  can-
er metastasis  of  L3.
ifferent  tumor  subgroups.  Corpectomies  and  vertebrec-
omies  increased  the  number  of  transfused  red  blood  cell
nits  compared  to  the  groups  decompression  with  instru-
entation  and  cervical  corpectomy  (Table  2).
ntraoperative  hemoglobin  decrease
he  same  observation  was  observed  for  the  hemoglobin
ariation  from  the  beginning  to  the  end  of  surgery  in  dif-
erent  tumor  subgroups.  Corpectomies  and  vertebrectomies
ncreased  the  hemoglobin  difference  compared  to  decom-
ressions  with  instrumentation  and  cervical  corpectomies
Table  3).
nﬂuence  of  embolisation  in  different  tumor
ubgroups
he  numbers  of  embolized  and  non-embolized  patients
orted  by  type  of  surgical  intervention  are  demonstrated  in
able  4  for  each  tumor  subgroup.
In  the  breast  cancer  group,  eight  patients  were
mbolized  and  20  patients  were  operated  without  emboliza-
ion.  Six  out  of  eight  embolized  patients  underwent  a
ertebrectomy  or  a  corpectomy.  The  linear  regression
odel  and  the  Poisson  model  adjusted  on  the  type  of
urgery  indicated  that  the  blood  loss  was  not  signiﬁcantly
ncreased  for  non-embolized  patients  who  received  a  thora-
olumbar  instrumentation  and  decompression  or  a  cervical
orpectomy  for  the  different  parameters:  blood  volume  in
uction  (P  =  0.235),  number  of  transfused  packed  red  blood
ells  units  (P  =  0.404),  hemoglobin  variation  (P  = 0.754).
 case  of  single  metastasis  of  L3  is  illustrated  in  Fig.  1.
his  patient  underwent  embolization  which  occluded  the
umor  vascularisation  (Fig.  2)  prior  to  surgical  treatment  by
ertebrectomy  of  L3  and  posterior  instrumentation  from  L2
o  L5  (Fig.  3).
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Table  1  Average  blood  volume  in  suction  (ml)  during  surgery  for  each  group  of  primary  tumor  and  for  each  category  of  surgical
procedure.
Posterior  instrumentation
and  decompression
Thoracolumbar  corpectomy
or vertebrectomy
Cervical  corpectomy  P-valuea
Breast  778  1775  600  0.048
Pulmonary  480  2500  180  0.036
Renal 1175  3346  780  0.020
Others 474  1550  40  0.020
a Comparison corpectomy or vertebrectomy versus instrumentation and decompression/cervical corpectomy.
Table  2  Average  number  transfused  packed  red  blood  cells  units  for  each  group  of  primary  tumor  and  for  each  category  of
surgical procedure.
Posterior  instrumentation
and  decompression
Thoracolumbar  corpectomy
or vertebrectomy
Cervical  corpectomy  P-valuea
Breast  1.2  4.6  0  0.002
Pulmonary  0.4  3.5  0  0.007
Renal 2.7  4.0  0  0.006
Others 0.4  2.8  0  0.001
a Comparison corpectomy or vertebrectomy versus instrumentation and decompression/cervical corpectomy.
Table  3  Average  intraoperative  hemoglobin  decrease  (g/dl)  for  each  group  of  primary  tumor  and  for  each  category  of  surgical
procedure.
Posterior  instrumentation
and  decompression
Thoracolumbar  corpectomy
or vertebrectomy
Cervical  corpectomy  P-valuea
Breast  3.6  8.0  2.7  0.090
Pulmonary  2.8  7.1  2.9  0.260
Renal 4.4  7.9  3.3  0.078
Others 2.4  4.9  2.0  0.003
a Comparison corpectomy or vertebrectomy versus instrumentation and decompression/cervical corpectomy.
Table  4  Number  of  embolized  and  non-embolized  patients  sorted  by  tumor  subgroups  and  type  of  surgery.
Instrumentation  and  decompression Corpectomy  or  vertebrectomy  Cervical  corpectomy  Total
Embolized  Non-embolized  Embolized  Non-embolized  Embolized  Non-embolized
Breast  2  15  6  1  0  4  28
Pulmonary 2  13  1  1  0  2  19
Renal 6  1  8  0  1  0  16
Others 3  10  6  6  0  5  30
p
r
b
e
f
fTotal 13  39  21  
In  the  group  of  pulmonary  tumors,  three  patients  were
embolized  and  16  patients  were  non-embolized.  One  out
of  three  embolized  patients  underwent  a  vertebrectomy.
The  statistical  models  did  not  indicate  a  signiﬁcant  dif-
ference  between  embolized  and  non-embolized  patients:
blood  volume  in  suction  (P  =  0.094),  number  of  transfused
packed  red  blood  cells  units  (P  =  0.273),  hemoglobin  varia-
tion  (P  =  0.960).
In  the  group  of  renal  cell  carcinoma,  15  out  of  16  patients
were  embolized.  The  single  patient  who  was  not  embolized
e
w
e8  1  11  93
resented  with  an  acute  paraplegia  and  underwent  a  tho-
acic  instrumentation  and  decompression  which  led  to  a
lood  loss  of  2000  ml.  A  statistical  comparison  between
mbolized  and  non-embolized  patients  could  not  be  per-
ormed  in  this  subgroup.  The  intraoperative  blood  loss  varied
rom  100  to  8750  ml  in  patients  who  underwent  preoperative
mbolization.
In  the  group  of  other  tumors,  nine  patients  under-
ent  embolization  and  21  patients  were  operated  without
mbolization.  One  out  of  three  embolized  patients
540  N.  Robial  et  al.
Figure  2  Preoperative  angiography  showing  the  tumoral  blush  of  L
on bottom  images.
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ticles  leads  to  a  signiﬁcant  reduction  of  blood  loss  duringigure  3  Postoperative  radiographs  after  vertebrectomy  of
3 and  posterior  instrumentation  from  L2  to  L5.
nderwent  a  vertebrectomy.  A  signiﬁcant  difference
etween  embolized  and  non-embolized  patients  could  not
e  lined  out  using  statistical  models:  blood  volume  in  suc-
ion  (P  =  0.994),  number  of  transfused  packed  red  blood
ells  units  (P  =  0.691),  hemoglobin  variation  (P  =  0.963).  In
s
c
a3  on  images  at  the  top  and  devascularisation  after  embolization
his  group,  the  two  patients  with  metastasis  of  thyroid
arcinoma  underwent  a cervical  corpectomy  without  pre-
perative  embolization  and  had  an  intraoperative  blood  loss
f  500  and  800  ml  respectively.
iscussion
ransarterial  embolization  represents  a  useful  method  of
ecreasing  intraoperative  bleeding  in  certain  metastatic
esions  of  the  spine  [1].  Historically,  gelfoam  particles  were
ushed  through  a  catheter  into  the  tumor  vascular  bed  [9].
ther  materials  such  as  dura-isobutyl  or  polyvinyl  alcohol
PVA)  were  also  used  [6].  The  efﬁcacy  of  coils  in  vertebral
etastases  remains  controversial,  since  larger  particles  may
cclude  pretumoral  arterial  branches  but  without  complete
lling  of  the  microvascular  structures  of  the  tumor  [2,10].
icrospheres  might  be  preferable  to  achieve  a  complete
mbolization  and  to  further  delay  the  revascularization  of
he  tumor  [11]. The  use  of  PVA  or  gelatin  sponge  micropar-urgery  [3].  However,  in  some  tumors  such  as  renal  cell  car-
inoma,  the  use  of  coils  seems  to  be  ineffective  because  of
n  angiomatous  vascularity  [12].
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Several  studies  [2,3,8,13]  have  shown  that  emboliza-
tion  is  particularly  valuable  in  metastases  of  renal  cell
carcinoma  which  present  an  elevated  risk  of  hemorrhage.
Recently,  Wilson  et  al.  [14]  have  compared  the  risk  of
intraoperative  bleeding  in  different  tumor  types  and  demon-
strated  that  renal  cell  carcinoma  was  associated  with  a
signiﬁcantly  higher  risk  of  hemorrhage.  Roscoe  et  al.  [4]
described  catastrophic  intraoperative  hemorrhage  during
surgical  stabilization  of  pathologic  fractures  due  to  renal
cell  carcinoma,  which  can  lead  to  life  threatening  conditions
for  the  patient.  Olerud  et  al.  [5]  mentioned  uncontrollable
bleeding  of  15000  ml  in  a  patient  who  underwent  a  verte-
brectomy  and  died  four  days  after  surgery.  Manke  et  al.  [12]
reported  a  median  blood  loss  of  1500  ml  (300  to  8000  ml)
in  17  embolized  patients  versus  5000  ml  (1440  to  15000  ml)
in  10  non-embolized  patients.  It  is  therefore  current  prac-
tice  to  perform  a  diagnostic  spinal  angiography  followed
by  embolization  when  feasible  in  all  patients  with  renal
metastatic  lesions  to  the  spine  in  whom  surgical  resec-
tion  is  planned  15.  Even  partial  embolization  of  renal  cell
metastatic  lesions  seems  to  reduce  blood  loss  compared
to  non-embolized  tumors  [12]. However,  in  spite  of  favor-
able  results  in  renal  cell  carcinoma,  radical  preoperative
embolization  is  not  always  a  guarantee  of  avoiding  extreme
blood  loss  during  surgery  [13,15].  This  is  concordant  with
our  ﬁndings,  which  found  an  extremely  variable  blood  loss
between  different  patients  ranging  from  100  to  8750  ml
despite  embolization.
Metastases  of  follicular  and  papillary  thyroid  carcinoma
are  classiﬁed  as  hypervascular  tumors  and  preoperative
embolisation  seems  to  be  beneﬁcial  in  reducing  the  amount
of  blood  loss  [1,2,16,17]. The  arterial  feeder  vessels  to
these  hypervascular  tumors  are  usually  large  and  accessi-
ble  by  superselective  microcatheterization  [6,7]. However,
the  number  of  patients  in  these  studies  remains  relatively
low.  In  our  series,  the  two  patients  who  underwent  cervical
corpectomy  without  embolization  lost  a  blood  volume  of  500
and  800  ml  respectively,  which  is  contradictory  with  previ-
ous  ﬁndings.  Smit  et  al.  [6]  reported  that  embolisation  of
metastases  of  follicular  thyroid  carcinoma  could  effectively
diminish  the  vascular  supply  of  vertebral  tumoral  lesions
and  qualiﬁed  this  procedure  as  an  attractive  option  when
performing  a  surgical  decompression  in  combination  with
irradiation  and  radioiodine  therapy.  Court  et  al.  [7]  reported
on  18  patients  with  metastasis  of  thyroid  carcinoma  and
recommend  a  systematic  preoperative  embolization.
Radeleff  et  al.  [1]  and  Vetter  et  al.  [16]  reported  on  some
patients  who  underwent  preoperative  embolization  of  spinal
metastases  of  breast  cancer  and  Guzman  et  al.  [18]  included
one  patient  with  metastasis  of  bronchial  carcinoma  in  his
series.  However,  a  possible  beneﬁt  of  embolization  was  not
described  in  these  studies,  compared  to  the  positive  effect
noticed  in  renal  cell  carcinoma,  thyroid  carcinoma  or  hep-
atocellular  carcinoma.  In  the  present  study,  the  mammary
or  pulmonary  origins  of  spinal  metastases  did  not  seem  to
appear  as  predictive  factors  for  increased  intraoperative
bleeding.  Embolization  does  not  seem  to  have  a  signiﬁ-
cant  inﬂuence  the  average  volume  of  blood  loss.  However,
only  eight  patients  were  embolized  in  the  breast  cancer
group  and  three  patients  in  the  pulmonary  tumor  group.
Seven  of  these  patients  underwent  thoracolumbar  corpec-
tomies  or  vertebrectomies.  It  remains  difﬁcult  to  properly
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nalyze  the  real  effect  of  embolization  from  this  retrospec-
ive  data.  Rehak  et  al.  [13]  described  a  2.7-time  higher  blood
oss  in  embolized  patients  in  comparison  to  non-embolized
atients.  This  is  probably  due  to  the  fact  that  a  patient
election  is  performed  by  the  surgeon  preoperatively.  This
epresents  a bias  in  the  evaluation  of  retrospective  data
hich  has  to  be  considered  in  our  study.
Major  interventions  such  as  thoracolumbar  corpectomies
r  vertebrectomies  increased  the  average  volume  of  blood
oss  in  any  type  of  spinal  metastasis  which  is  related  to  the
xtent  of  the  surgical  technique.  These  indications  should  be
estricted  to  single  metastasis  which  are  relatively  rare  com-
ared  to  palliative  procedures  such  as  decompression  and
nstrumentation  in  patients  with  multiple  metastasis.  Berke-
eld  et  al.  [10]  described  an  average  blood  loss  of  4350  ml  in
on-embolized  patients  who  underwent  a  corpectomy  ver-
us  2650  ml  in  patients  who  received  an  embolization  with
oils,  1800  ml  with  PVA  particles  and  1850  ml  with  PVA  par-
icles  and  coils.  Olerud  et  al.  [5]  reported  an  average  blood
oss  of  6200  ml  in  non-embolized  patients  versus  4300  ml
fter  embolization  with  gelfoam  or  PVA  particles.  Boudghene
t  al.  [19]  found  an  average  blood  loss  of  5900  ml  without
mbolization  and  2800  ml  after  embolization  with  PVA  par-
icles.  In  our  study,  the  average  intraoperative  blood  loss
anged  between  1550  ml  in  other  tumors,  1775  ml  in  breast
ancer  metastases,  2500  ml  in  pulmonary  tumor  metastases
nd  3346  ml  in  renal  in  patients  who  underwent  a  corpec-
omy  or  vertebrectomy.  Nevertheless,  it  remains  difﬁcult  to
redict  which  spinal  metastasis,  apart  from  renal  cell  car-
inoma,  will  be  hypervascular.  As  shown  in  Fig.  2,  spinal
etastases  of  breast  cancer  may  present  a  developed  tumor
ascularity.  Imaging  which  enables  to  evidence  the  possible
ypervascular  character  is  therefore  recommended  in  any
ype  of  tumor  prior  to  major  surgical  interventions.
Prabhu  et  al.  [8]  report  a  positive  predictive  value  of
7%  of  magnetic  resonance  imaging  (MRI)  in  the  determina-
ion  of  tumor  vascularity.  The  criteria  for  hypervascularity
nclude  bright  contrast  enhancement,  large  signal  voids  rep-
esenting  blood  vessels  or  the  evidence  of  intratumoral
emorrhage,  and  arteriovenous  shunts.  However,  hyper-
ascular  tumors  may  not  be  detected  by  standard  MRI
equences.  Spinal  angiography  allows  determining  the  tumor
ascularity  as  well  as  a  possible  relationship  with  the
damkiewicz  artery  and  radiculo-medullary  arteries,  which
upply  the  anterior  spinal  artery  [20]. Furthermore,  angiog-
aphy  allows  performing  an  embolization  through  the  same
rocedure.  Thus,  angiography  represents  an  appropriate
rocedure  in  any  tumor  type  prior  to  complex  surgeries  such
s  corpectomy  or  vertebrectomy.
onclusion
reoperative  embolization  represents  a  valuable  method
hich  allows  decreasing  the  risk  of  intraoperative  hemor-
hage  in  hypervascular  spinal  metastases  such  as  renal  cell
arcinoma.  A  beneﬁt  of  embolization  could  not  be  lined
ut  for  metastases  of  breast  cancer  and  pulmonary  tumors.
he  group  of  other  metastases,  especially  thyroid  carci-
oma,  needs  to  be  further  analyzed  on  a  greater  cohort.
he  extent  of  surgery  remains  an  important  risk  factor  for
ntraoperative  bleeding.  A  preoperative  angiogram  should
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e  carried  out  in  all  types  of  metastases  prior  to  a  thora-
olumbar  corpectomy  or  vertebrectomy  in  order  to  perform
n  embolization  if  the  tumor  is  hypervascular.
isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
eferences
[1] Radeleff B, Eiers M, Lopez-Benitez R, et al. Transarterial
embolization of primary and secondary tumors of the skeletal
system. Eur J Radiol 2006;58:68—75.
[2] Hess T, Kramann B, Schmidt E, et al. Use of preoperative vas-
cular embolisation in spinal metastasis resection. Arch Orthop
Trauma Surg 1997;116:279—82.
[3] Chatziioannou AN, Johnson ME, Pneumaticos SG, et al. Pre-
operative embolization of bone metastases from renal cell
carcinoma. Eur Radiol 2000;10:593—6.
[4] Roscoe MW, McBroom RJ, St Louis E, Grossman H, Perrin
R. Preoperative embolization in the treatment of osseous
metastases from renal cell carcinoma. Clin Orthop Relat Res
1989;238:302—7.
[5] Olerud C, Jonsson Jr H, Lofberg AM, et al. Embolization of
spinal metastases reduces peroperative blood loss. Twenty-one
patients operated on for renal cell carcinoma. Acta Orthop
Scand 1993;64:9—12.
[6] Smit JW, Vielvoye GJ, Goslings BM. Embolization for vertebral
metastases of follicular thyroid carcinoma. J Clin Endocrinol
Metab 2000;85:989—94.
[7] Court C, Noun Z, Gagey O, et al. Surgical treatment of
metastases from thyroid cancer in the axial skeleton. A ret-
rospective study of 18 cases. Acta Orthop Belg 2000;66:
345—52.
[8] Prabhu VC, Bilsky MH, Jambhekar K, et al. Results of preopera-
tive embolization for metastatic spinal neoplasms. J Neurosurg
2003;98:156—64.
[N.  Robial  et  al.
[9] Feldman F, Casarella WJ, Dick HM, et al. Selective intra-arterial
embolization of bone tumors. A useful adjunct in the manage-
ment of selected lesions. Am J Roentgenol Radium Ther Nucl
Med 1975;123:130—9.
10] Berkefeld J, Scale D, Kirchner J, et al. Hypervascular spinal
tumors: inﬂuence of the embolization technique on perioper-
ative hemorrhage. AJNR Am J Neuroradiol 1999;20:757—63.
11] Basile A, Rand T, Lomoschitz F, et al. Trisacryl gelatin micro-
spheres versus polyvinyl alcohol particles in the preoperative
embolization of bone neoplasms. Cardiovasc Intervent Radiol
2004;27:495—502.
12] Manke C, Bretschneider T, Lenhart M, et al. Spinal metas-
tases from renal cell carcinoma: effect of preoperative particle
embolization on intraoperative blood loss. AJNR Am J Neuro-
radiol 2001;22:997—1003.
13] Rehak S, Krajina A, Ungermann L, et al. The role of
embolization in radical surgery of renal cell carcinoma spinal
metastases. Acta Neurochir (Wien) 2008;150:1177—81 [discus-
sion 81].
14] Wilson MA, Cooke DL, Ghodke B, et al. Retrospective analy-
sis of preoperative embolization of spinal tumors. AJNR Am J
Neuroradiol 2010;31:656—60.
15] Breslau J, Eskridge JM. Preoperative embolization of spinal
tumors. J Vasc Interv Radiol 1995;6:871—5.
16] Vetter SC, Strecker EP, Ackermann LW, et al. Preoperative
embolization of cervical spine tumors. Cardiovasc Intervent
Radiol 1997;20:343—7.
17] Munk PL, Legiehn GM. Musculoskeletal interventional
radiology: applications to oncology. Semin Roentgenol
2007;42:164—74.
18] Guzman R, Dubach-Schwizer S, Heini P, et al. Preoperative
transarterial embolization of vertebral metastases. Eur Spine
J 2005;14:263—8.
19] Boudghene F, Breittmayer F, Le Breton C, et al. Preop-
erative embolization of vertebral tumors: assessment in a
retrospective study of 20 cases. Cardiovasc Intervent Radiol
1994;17(Suppl 2):79.
20] Charles YP, Barbe B, Beaujeux R, et al. Relevance of the
anatomical location of the Adamkiewicz artery in spine surgery.
Surg Radiol Anat 2011;33:3—9.
